AnaptysBio Inc (ANAB)
21.32
+0.15
(+0.71%)
USD |
NASDAQ |
Nov 22, 10:54
AnaptysBio 1 Year Total Returns (Daily): 49.40% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 49.40% |
November 20, 2024 | 39.97% |
November 19, 2024 | 34.03% |
November 18, 2024 | 26.71% |
November 15, 2024 | 32.04% |
November 14, 2024 | 34.38% |
November 13, 2024 | 48.32% |
November 12, 2024 | 50.35% |
November 11, 2024 | 56.64% |
November 08, 2024 | 37.48% |
November 07, 2024 | 30.08% |
November 06, 2024 | 33.23% |
November 05, 2024 | 13.41% |
November 04, 2024 | 13.75% |
November 01, 2024 | 31.08% |
October 31, 2024 | 32.62% |
October 30, 2024 | 34.51% |
October 29, 2024 | 88.38% |
October 28, 2024 | 86.48% |
October 25, 2024 | 81.78% |
October 24, 2024 | 82.55% |
October 23, 2024 | 97.89% |
October 22, 2024 | 94.74% |
October 21, 2024 | 95.96% |
October 18, 2024 | 89.08% |
Date | Value |
---|---|
October 17, 2024 | 85.94% |
October 16, 2024 | 87.31% |
October 15, 2024 | 76.59% |
October 14, 2024 | 84.39% |
October 11, 2024 | 70.80% |
October 10, 2024 | 63.35% |
October 09, 2024 | 57.54% |
October 08, 2024 | 68.05% |
October 07, 2024 | 71.43% |
October 04, 2024 | 84.07% |
October 03, 2024 | 90.07% |
October 02, 2024 | 98.53% |
October 01, 2024 | 93.82% |
September 30, 2024 | 86.53% |
September 27, 2024 | 72.55% |
September 26, 2024 | 79.12% |
September 25, 2024 | 86.61% |
September 24, 2024 | 106.8% |
September 23, 2024 | 110.8% |
September 20, 2024 | 113.8% |
September 19, 2024 | 102.4% |
September 18, 2024 | 89.78% |
September 17, 2024 | 92.31% |
September 16, 2024 | 98.56% |
September 13, 2024 | 106.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.54%
Minimum
Nov 22 2019
192.1%
Maximum
Nov 10 2020
0.52%
Average
-4.86%
Median
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 27.37% |
Regeneron Pharmaceuticals Inc | -6.80% |
Ligand Pharmaceuticals Inc | 99.30% |
Agios Pharmaceuticals Inc | 154.0% |
ADMA Biologics Inc | 440.6% |